MK-0431/ONO-5435 phase III clinical study - long-term treatment study for patients with type 2 diabetes mellitus
Phase of Trial: Phase III
Latest Information Update: 27 May 2016
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Ono Pharmaceutical
- 31 Aug 2018 Biomarkers information updated
- 28 Jul 2008 Actual end date and patient numbers added from NCT.
- 14 Jun 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.